Gui et al. (211) have shown that plasma levels of Cer(d18:1/16:0), Cer(d18:1/22:0), and Cer(d18:1/24:0) were significantly higher in stroke patients than in patients from the control group. The gene discussed is CBLN1; the disease is stroke disorder.